As of 2025-05-18, the Fair Value of Bone Therapeutics SA (BOTHE.BR) is -2.75 EUR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.14 EUR, the upside of Bone Therapeutics SA is -2,010.50%.
With the market price of 0.14 EUR and our fair value calculation, Bone Therapeutics SA (BOTHE.BR) is not a good investment. Investing in BOTHE.BR stocks now will result in a potential loss of 2,010.50%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | - | - | 5Y Avg | |
| Net income | -12.93 | -2.04 | - | - | -7.48 | |
| YoY growth | -8.24% | 84.21% | - | - | 37.98% | |
| Market Cap (mil) | 2.67 |
| P/E | |
| Forward P/E |
| EPS | -0.11 |
| Avg earnings growth rate | 37.98% |
| TTM earnings | -2.04 |